<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35699446</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>13</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>An <i>In Vivo</i> Model of Echovirus-Induced Meningitis Defines the Differential Roles of Type I and Type III Interferon Signaling in Central Nervous System Infection.</ArticleTitle><Pagination><StartPage>e0033022</StartPage><MedlinePgn>e0033022</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00330-22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.00330-22</ELocationID><Abstract><AbstractText>Echoviruses are among the most common worldwide causes of aseptic meningitis, which can cause long-term sequelae and death, particularly in neonates. However, the mechanisms by which these viruses induce meningeal inflammation are poorly understood, owing at least in part to the lack of <i>in vivo</i> models that recapitulate this aspect of echovirus pathogenesis. Here, we developed an <i>in vivo</i> neonatal mouse model that recapitulates key aspects of echovirus-induced meningitis. We show that expression of the human homologue of the primary echovirus receptor, the neonatal Fc receptor (FcRn), is not sufficient for infection of the brains of neonatal mice. However, ablation of type I, but not III, interferon (IFN) signaling in mice expressing human FcRn permitted high levels of echovirus replication in the brain, with corresponding clinical symptoms, including delayed motor skills and hind-limb weakness. Using this model, we defined the immunological response of the brain to echovirus infection and identified key cytokines, such as granulocyte colony-stimulating factor (G-CSF) and interleukin 6 (IL-6), that were induced by this infection. Lastly, we showed that echoviruses specifically replicate in the leptomeninges, where they induce profound inflammation and cell death. Together, this work establishes an <i>in vivo</i> model of aseptic meningitis associated with echovirus infections that delineates the differential roles of type I and type III IFNs in echovirus-associated neuronal disease and defines the specificity of echoviral infections within the meninges. <b>IMPORTANCE</b> Echoviruses are among the most common worldwide causes of aseptic meningitis, which can cause long-term sequelae or even death. The mechanisms by which echoviruses infect the brain are poorly understood, largely owing to the lack of robust <i>in vivo</i> models that recapitulate this aspect of echovirus pathogenesis. Here, we establish a neonatal mouse model of echovirus-induced aseptic meningitis and show that expression of the human homologue of the FcRn, the primary receptor for echoviruses, and ablation of type I IFN signaling are required to recapitulate echovirus-induced meningitis and clinical disease. These findings provide key insights into the host factors that control echovirus-induced meningitis and a model that could be used to test anti-echovirus therapeutics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wells</LastName><ForeName>Alexandra I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics and Microbiology, Duke University School of Medicinegrid.471396.e, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coyne</LastName><ForeName>Carolyn B</ForeName><Initials>CB</Initials><Identifier Source="ORCID">0000-0002-1884-6309</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics and Microbiology, Duke University School of Medicinegrid.471396.e, Durham, North Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Human Vaccine Institute, Duke University School of Medicinegrid.471396.e, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F31 AI149866</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI150151</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI060525</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000095022">Interferon Lambda</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002494" MajorTopicYN="Y">Central Nervous System Infections</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004457" MajorTopicYN="Y">Echovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008582" MajorTopicYN="Y">Meningitis, Aseptic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095022" MajorTopicYN="N">Interferon Lambda</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aseptic meningitis</Keyword><Keyword MajorTopicYN="N">echovirus</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">in vivo</Keyword><Keyword MajorTopicYN="N">neonatal Fc receptor</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>14</Day><Hour>9</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35699446</ArticleId><ArticleId IdType="pmc">PMC9278148</ArticleId><ArticleId IdType="doi">10.1128/jvi.00330-22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Berlin LE, Rorabaugh ML, Heldrich F, Roberts K, Doran T, Modlin JF. 1993. Aseptic meningitis in infants &lt;2 years of age: diagnosis and etiology. J Infect Dis 168:888&#x2013;892. 10.1093/infdis/168.4.888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/168.4.888</ArticleId><ArticleId IdType="pubmed">8397269</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Morse D, Slater B, Anand M, Tobin E, Smith P, Dupuis M, Hull R, Ferrera R, Rosen B, Grady L. 2004. Multiple-year experience in the diagnosis of viral central nervous system infections with a panel of polymerase chain reaction assays for detection of 11 viruses. Clin Infect Dis 39:630&#x2013;635. 10.1086/422650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/422650</ArticleId><ArticleId IdType="pubmed">15356774</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotbart HA. 1995. Enteroviral infections of the central nervous system. Clin Infect Dis 20:971&#x2013;981. 10.1093/clinids/20.4.971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/20.4.971</ArticleId><ArticleId IdType="pubmed">7795102</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. 2003. Outbreaks of aseptic meningitis associated with echoviruses 9 and 30 and preliminary surveillance reports on enterovirus activity&#x2013;United States, 2003. MMWR Morb Mortal Wkly Rep 52:761&#x2013;764.</Citation><ArticleIdList><ArticleId IdType="pubmed">12917581</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H-Y, Chen C-J, Huang Y-C, Li W-C, Chiu C-H, Huang C-G, Tsao K-C, Wu C-T, Lin T-Y. 2010. Clinical features of echovirus 6 and 9 infections in children. J Clin Virol 49:175&#x2013;179. 10.1016/j.jcv.2010.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2010.07.010</ArticleId><ArticleId IdType="pubmed">20729140</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H-J, Kang B, Hwang S, Hong J, Kim K, Cheon D-S. 2012. Epidemics of viral meningitis caused by echovirus 6 and 30 in Korea in 2008. Virol J 9:38. 10.1186/1743-422X-9-38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-38</ArticleId><ArticleId IdType="pmc">PMC3298778</ArticleId><ArticleId IdType="pubmed">22336050</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang YY, Huang YC. 2019. Enteroviral infection in neonates. J Microbiol Immunol Infect 52:851&#x2013;857. 10.1016/j.jmii.2019.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2019.08.018</ArticleId><ArticleId IdType="pubmed">31607572</ArticleId></ArticleIdList></Reference><Reference><Citation>Modlin JF. 1986. Perinatal echovirus infection: insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries. Rev Infect Dis 8:918&#x2013;926. 10.1093/clinids/8.6.918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/8.6.918</ArticleId><ArticleId IdType="pubmed">3541126</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. 2006. Enterovirus surveillance&#x2013;United States, 2002&#x2013;2004. MMWR Morb Mortal Wkly Rep 55:153&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">16484979</ArticleId></ArticleIdList></Reference><Reference><Citation>Morosky S, Wells AI, Lemon K, Evans AS, Schamus S, Bakkenist CJ, Coyne CB. 2019. The neonatal Fc receptor is a pan-echovirus receptor. Proc Natl Acad Sci USA 116:3758&#x2013;3763. 10.1073/pnas.1817341116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1817341116</ArticleId><ArticleId IdType="pmc">PMC6397586</ArticleId><ArticleId IdType="pubmed">30808762</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Zhang G, Liu S, Chen X, Peng R, Dai L, Qu X, Li S, Song H, Gao Z, Yuan P, Liu Z, Li C, Shang Z, Li Y, Zhang M, Qi J, Wang H, Du N, Wu Y, Bi Y, Gao S, Shi Y, Yan J, Zhang Y, Xie Z, Wei W, Gao GF. 2019. Human neonatal Fc receptor is the cellular uncoating receptor for enterovirus B. Cell 177:1553&#x2013;1565.e1516. 10.1016/j.cell.2019.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.04.035</ArticleId><ArticleId IdType="pmc">PMC7111318</ArticleId><ArticleId IdType="pubmed">31104841</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyzik M, Rath T, Lencer WI, Baker K, Blumberg RS. 2015. FcRn: the architect behind the immune and nonimmune functions of IgG and albumin. J Immunol 194:4595&#x2013;4603. 10.4049/jimmunol.1403014.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1403014</ArticleId><ArticleId IdType="pmc">PMC4451002</ArticleId><ArticleId IdType="pubmed">25934922</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyzik M, Rath T, Kuo TT, Win S, Baker K, Hubbard JJ, Grenha R, Gandhi A, Kr&#xe4;mer TD, Mezo AR, Taylor ZS, McDonnell K, Nienaber V, Andersen JT, Mizoguchi A, Blumberg L, Purohit S, Jones SD, Christianson G, Lencer WI, Sandlie I, Kaplowitz N, Roopenian DC, Blumberg RS. 2017. Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury. Proc Natl Acad Sci USA 114:E2862&#x2013;E2871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5389309</ArticleId><ArticleId IdType="pubmed">28330995</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhury C, Mehnaz S, Robinson JM, Hayton WL, Pearl DK, Roopenian DC, Anderson CL. 2003. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 197:315&#x2013;322. 10.1084/jem.20021829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20021829</ArticleId><ArticleId IdType="pmc">PMC2193842</ArticleId><ArticleId IdType="pubmed">12566415</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Pardridge WM. 2001. Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier. J Neuroimmunol 114:168&#x2013;172. 10.1016/S0165-5728(01)00242-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-5728(01)00242-9</ArticleId><ArticleId IdType="pubmed">11240028</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlachetzki F, Zhu C, Pardridge WM. 2002. Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier. J Neurochem 81:203&#x2013;206. 10.1046/j.1471-4159.2002.00840.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2002.00840.x</ArticleId><ArticleId IdType="pubmed">12067234</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn J, Choi J, Joo CH, Seo I, Kim D, Yoon SY, Kim YK, Lee H. 2004. Susceptibility of mouse primary cortical neuronal cells to coxsackievirus B. J Gen Virol 85:1555&#x2013;1564. 10.1099/vir.0.19695-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.19695-0</ArticleId><ArticleId IdType="pubmed">15166439</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuer R, Pagarigan RR, Harkins S, Liu F, Hunziker IP, Whitton JL. 2005. Coxsackievirus targets proliferating neuronal progenitor cells in the neonatal CNS. J Neurosci 25:2434&#x2013;2444. 10.1523/JNEUROSCI.4517-04.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4517-04.2005</ArticleId><ArticleId IdType="pmc">PMC6726081</ArticleId><ArticleId IdType="pubmed">15745971</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuer R, Mena I, Pagarigan RR, Harkins S, Hassett DE, Whitton JL. 2003. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am J Pathol 163:1379&#x2013;1393. 10.1016/S0002-9440(10)63496-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)63496-7</ArticleId><ArticleId IdType="pmc">PMC1868316</ArticleId><ArticleId IdType="pubmed">14507646</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes SA, Thaker HM, Racaniello VR. 2003. Transgenic mouse model for echovirus myocarditis and paralysis. Proc Natl Acad Sci USA 100:15906&#x2013;15911. 10.1073/pnas.2535934100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2535934100</ArticleId><ArticleId IdType="pmc">PMC307666</ArticleId><ArticleId IdType="pubmed">14673080</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G, Li J, Sun Q, Zhang K, Xu W, Zhang Y, Wu G. 2021. Pathological features of echovirus-11-associated brain damage in mice based on RNA-Seq analysis. Viruses 13:2477. 10.3390/v13122477.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13122477</ArticleId><ArticleId IdType="pmc">PMC8707869</ArticleId><ArticleId IdType="pubmed">34960747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells AI, Grimes KA, Kim K, Branche E, Bakkenist CJ, DePas WH, Shresta S, Coyne CB. 2021. Human FcRn expression and type I interferon signaling control echovirus 11 pathogenesis in mice. PLoS Pathog 17:e1009252. 10.1371/journal.ppat.1009252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009252</ArticleId><ArticleId IdType="pmc">PMC7875378</ArticleId><ArticleId IdType="pubmed">33513208</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishikawa M, Matsubara T, Yoshitomi T, Ichiyama T, Hayashi T, Furukawa S. 2000. Abnormalities of brain perfusion in echovirus type 30 meningitis. J Neurol Sci 179:122&#x2013;126. 10.1016/S0022-510X(00)00398-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(00)00398-1</ArticleId><ArticleId IdType="pubmed">11054495</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S-M, Lei H-Y, Su L-Y, Wu J-M, Yu C-K, Wang J-R, Liu C-C. 2007. Cerebrospinal fluid cytokines in enterovirus 71 brain stem encephalitis and echovirus meningitis infections of varying severity. Clin Microbiol Infect 13:677&#x2013;682. 10.1111/j.1469-0691.2007.01729.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2007.01729.x</ArticleId><ArticleId IdType="pubmed">17441979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichiyama T, Maeba S, Suenaga N, Saito K, Matsubara T, Furukawa S. 2005. Analysis of cytokine levels in cerebrospinal fluid in mumps meningitis: comparison with echovirus type 30 meningitis. Cytokine 30:243&#x2013;247. 10.1016/j.cyto.2005.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2005.01.022</ArticleId><ArticleId IdType="pubmed">15927848</ArticleId></ArticleIdList></Reference><Reference><Citation>Chonmaitree T, Baron S. 1991. Bacteria and viruses induce production of interferon in the cerebrospinal fluid of children with acute meningitis: a study of 57 cases and review. Rev Infect Dis 13:1061&#x2013;1065. 10.1093/clinids/13.6.1061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/13.6.1061</ArticleId><ArticleId IdType="pubmed">1723215</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh H, Koury J, Kaul M. 2021. Innate immune sensing of viruses and its consequences for the central nervous system. Viruses 13:170. 10.3390/v13020170.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020170</ArticleId><ArticleId IdType="pmc">PMC7912342</ArticleId><ArticleId IdType="pubmed">33498715</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazear HM, Daniels BP, Pinto AK, Huang AC, Vick SC, Doyle SE, Gale M, Jr., Klein RS, Diamond MS. 2015. Interferon-&#x3bb; restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci Transl Med 7:284ra259. 10.1126/scitranslmed.aaa4304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa4304</ArticleId><ArticleId IdType="pmc">PMC4435724</ArticleId><ArticleId IdType="pubmed">25904743</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Zhao L, Luo Z, Zhang Y, Lv L, Zhao J, Sui B, Huang F, Cui M, Fu ZF, Zhou M. 2020. Interferon-&#x3bb; attenuates rabies virus infection by inducing interferon-stimulated genes and alleviating neurological inflammation. Viruses 12:405. 10.3390/v12040405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12040405</ArticleId><ArticleId IdType="pmc">PMC7232327</ArticleId><ArticleId IdType="pubmed">32268591</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells AI, Coyne CB. 2018. Type III interferons in antiviral defenses at barrier surfaces. Trends Immunol 39:848&#x2013;858. 10.1016/j.it.2018.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2018.08.008</ArticleId><ArticleId IdType="pmc">PMC6179363</ArticleId><ArticleId IdType="pubmed">30219309</ArticleId></ArticleIdList></Reference><Reference><Citation>Roopenian DC, Christianson GJ, Proetzel G, Sproule TJ. 2016. Human FcRn transgenic mice for pharmacokinetic evaluation of therapeutic antibodies. Methods Mol Biol 1438:103&#x2013;114. 10.1007/978-1-4939-3661-8_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-3661-8_6</ArticleId><ArticleId IdType="pubmed">27150086</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells AI, Grimes KA, Coyne CB. 2022. Enterovirus replication and dissemination are differentially controlled by type I and III interferons in the gastrointestinal tract. mBio 13:e00443-22. 10.1128/mbio.00443-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00443-22</ArticleId><ArticleId IdType="pmc">PMC9239134</ArticleId><ArticleId IdType="pubmed">35604122</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW. 1994. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci USA 91:6245&#x2013;6248. 10.1073/pnas.91.13.6245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.13.6245</ArticleId><ArticleId IdType="pmc">PMC44175</ArticleId><ArticleId IdType="pubmed">7517044</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi HMT, Schwarzkopf M, Fornace ME, Acharya A, Artavanis G, Stegmaier J, Cunha A, Pierce NA. 2018. Third-generation in situ hybridization chain reaction: multiplexed, quantitative, sensitive, versatile, robust. Development 145:dev165753. 10.1242/dev.165753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.165753</ArticleId><ArticleId IdType="pmc">PMC6031405</ArticleId><ArticleId IdType="pubmed">29945988</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi HMT, Calvert CR, Husain N, Huss D, Barsi JC, Deverman BE, Hunter RC, Kato M, Lee SM, Abelin ACT, Rosenthal AZ, Akbari OS, Li Y, Hay BA, Sternberg PW, Patterson PH, Davidson EH, Mazmanian SK, Prober DA, van de Rijn M, Leadbetter JR, Newman DK, Readhead C, Bronner ME, Wold B, Lansford R, Sauka-Spengler T, Fraser SE, Pierce NA. 2016. Mapping a multiplexed zoo of mRNA expression. Development 143:3632&#x2013;3637. 10.1242/dev.140137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.140137</ArticleId><ArticleId IdType="pmc">PMC5087610</ArticleId><ArticleId IdType="pubmed">27702788</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan J, Zhang L, Odenwald MA, Shen L, Turner JR, Bergelson JM. 2015. Expression of human decay-accelerating factor on intestinal epithelium of transgenic mice does not facilitate infection by the enteral route. J Virol 89:4311&#x2013;4318. 10.1128/JVI.03468-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03468-14</ArticleId><ArticleId IdType="pmc">PMC4442383</ArticleId><ArticleId IdType="pubmed">25653430</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper PR, Ciambrone GJ, Kliwinski CM, Maze E, Johnson L, Li Q, Feng Y, Hornby PJ. 2013. Efflux of monoclonal antibodies from rat brain by neonatal Fc receptor, FcRn. Brain Res 1534:13&#x2013;21. 10.1016/j.brainres.2013.08.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2013.08.035</ArticleId><ArticleId IdType="pubmed">23978455</ArticleId></ArticleIdList></Reference><Reference><Citation>Latvala S, Jacobsen B, Otteneder MB, Herrmann A, Kronenberg S. 2017. Distribution of FcRn across species and tissues. J Histochem Cytochem 65:321&#x2013;333. 10.1369/0022155417705095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/0022155417705095</ArticleId><ArticleId IdType="pmc">PMC5625855</ArticleId><ArticleId IdType="pubmed">28402755</ArticleId></ArticleIdList></Reference><Reference><Citation>DeSisto J, O'Rourke R, Jones HE, Pawlikowski B, Malek AD, Bonney S, Guimiot F, Jones KL, Siegenthaler JA. 2020. Single-cell transcriptomic analyses of the developing meninges reveal meningeal fibroblast diversity and function. Dev Cell 54:43&#x2013;59.e44. 10.1016/j.devcel.2020.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2020.06.009</ArticleId><ArticleId IdType="pmc">PMC7769050</ArticleId><ArticleId IdType="pubmed">32634398</ArticleId></ArticleIdList></Reference><Reference><Citation>Kierdorf K, Masuda T, Jordao MJC, Prinz M. 2019. Macrophages at CNS interfaces: ontogeny and function in health and disease. Nat Rev Neurosci 20:547&#x2013;562. 10.1038/s41583-019-0201-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-019-0201-x</ArticleId><ArticleId IdType="pubmed">31358892</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsubara T, Matsuoka T, Katayama K, Yoshitomi T, Nishikawa M, Ichiyama T, Furukawa S. 2000. Mononuclear cells and cytokines in the cerebrospinal fluid of echovirus 30 meningitis patients. Scand J Infect Dis 32:471&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">11055648</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond CG, Bolock AM, Ma C, Luke CJ, Good M, Coyne CB. 2017. Enteroviruses infect human enteroids and induce antiviral signaling in a cell lineage-specific manner. Proc Natl Acad Sci USA 114:1672&#x2013;1677. 10.1073/pnas.1617363114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1617363114</ArticleId><ArticleId IdType="pmc">PMC5320971</ArticleId><ArticleId IdType="pubmed">28137842</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman MC, Wells AI, Ciomperlik-Patton J, Myerburg MM, Yang L, Konopka-Anstadt J, Coyne CB. 2021. Respiratory and intestinal epithelial cells exhibit differential susceptibility and innate immune responses to contemporary EV-D68 isolates. Elife 10:e66687. 10.7554/eLife.66687.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.66687</ArticleId><ArticleId IdType="pmc">PMC8285104</ArticleId><ArticleId IdType="pubmed">34196272</ArticleId></ArticleIdList></Reference><Reference><Citation>Good C, Wells AI, Coyne CB. 2019. Type III interferon signaling restricts enterovirus 71 infection of goblet cells. Sci Adv 5:eaau4255. 10.1126/sciadv.aau4255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aau4255</ArticleId><ArticleId IdType="pmc">PMC6402847</ArticleId><ArticleId IdType="pubmed">30854425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuss SK, Etheredge CA, Pfeiffer JK. 2008. Multiple host barriers restrict poliovirus trafficking in mice. PLoS Pathog 4:e1000082. 10.1371/journal.ppat.1000082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000082</ArticleId><ArticleId IdType="pmc">PMC2390757</ArticleId><ArticleId IdType="pubmed">18535656</ArticleId></ArticleIdList></Reference><Reference><Citation>Bultmann BD, Eggers HJ, Galle J, Haferkamp O. 1983. Age dependence of paralysis induced by echovirus type 9 in infant mice. J Infect Dis 147:999&#x2013;1005. 10.1093/infdis/147.6.999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/147.6.999</ArticleId><ArticleId IdType="pubmed">6854075</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brown NM, Pfau SJ, Gu C. 2018. Bridging barriers: a comparative look at the blood-brain barrier across organisms. Genes Dev 32:466&#x2013;478. 10.1101/gad.309823.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.309823.117</ArticleId><ArticleId IdType="pmc">PMC5959231</ArticleId><ArticleId IdType="pubmed">29692355</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu AG, Pruijssers AJ, Brown JJ, Stencel-Baerenwald JE, Sutherland DM, Iskarpatyoti JA, Dermody TS. 2018. Age-dependent susceptibility to reovirus encephalitis in mice is influenced by maturation of the type-I interferon response. Pediatr Res 83:1057&#x2013;1066. 10.1038/pr.2018.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/pr.2018.13</ArticleId><ArticleId IdType="pmc">PMC5959747</ArticleId><ArticleId IdType="pubmed">29364865</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyden D, Olszewski J, Huber S. 1987. Variation in susceptibility of Balb/c mice to coxsackievirus group B type 3-induced myocarditis with age. Cell Immunol 105:332&#x2013;339. 10.1016/0008-8749(87)90081-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0008-8749(87)90081-5</ArticleId><ArticleId IdType="pubmed">3494528</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatib R, Chason JL, Silberberg BK, Lerner AM. 1980. Age-dependent pathogenicity of group B coxsackieviruses in Swiss-Webster mice: infectivity for myocardium and pancreas. J Infect Dis 141:394&#x2013;403. 10.1093/infdis/141.3.394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/141.3.394</ArticleId><ArticleId IdType="pubmed">6245156</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu X, Wang MZ. 2020. Quantification of neonatal Fc receptor and beta-2 microglobulin in human liver tissues by ultraperformance liquid chromatography-multiple reaction monitoring-based targeted quantitative proteomics for applications in biotherapeutic physiologically-based pharmacokinetic models. Drug Metab Dispos 48:925&#x2013;933. 10.1124/dmd.120.000075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/dmd.120.000075</ArticleId><ArticleId IdType="pmc">PMC7562974</ArticleId><ArticleId IdType="pubmed">32723849</ArticleId></ArticleIdList></Reference><Reference><Citation>Morosky S, Lennemann NJ, Coyne CB. 2016. BPIFB6 regulates secretory pathway trafficking and enterovirus replication. J Virol 90:5098&#x2013;5107. 10.1128/JVI.00170-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00170-16</ArticleId><ArticleId IdType="pmc">PMC4859712</ArticleId><ArticleId IdType="pubmed">26962226</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Nix WA, Maher K, Pallansch MA. 2003. Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J Clin Virol 26:375&#x2013;377. 10.1016/S1386-6532(03)00004-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(03)00004-0</ArticleId><ArticleId IdType="pubmed">12637088</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>